<\/b><\/p>\n
<\/b><\/p>\n
Here are what the editors at HealthDay consider to be the most important developments in Pathology for September 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.<\/p>\n
Surgeon Charged With Aggravated Assault Over Windpipe Transplants<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Charges of aggravated assault have been filed against a surgeon once hailed for creating the world’s first windpipe partially made from a patient’s own stem cells, a Swedish prosecutor says.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Review IDs Dietary Factors Linked to Lower CRC Incidence<\/font><\/p>\n WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Decreased colorectal cancer (CRC) incidence is seen in association with use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), magnesium, folate, and high consumption of fruits and vegetables, fiber, and dairy products, according to an umbrella review published online Sept. 28 in Gut<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Global Death Toll From COVID-19 Passes 1 Million<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — The global COVID-19 pandemic reached a grim new milestone on Tuesday: 1 million dead.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Johns Hopkins University<\/a><\/p>\n U.S. Government to Ship Millions of Rapid COVID-19 Tests This Week<\/font><\/p>\n TUESDAY, Sept. 29, 2020 (HealthDay News) — The U.S. government will start distributing millions of rapid COVID-19 tests to states this week with the goal of reopening schools.<\/p>\n AP News<\/i> Article<\/a><\/p>\n Private Health Plans Pay Hospitals 247 Percent of Medicare<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — During 2018, prices paid to hospitals by privately insured patients averaged 247 percent of what Medicare would have paid, according to a study from the RAND Corporation.<\/p>\n More Information<\/a><\/p>\n Clinical Severity Lower With Vitamin D Sufficiency in COVID-19<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Vitamin D sufficiency is associated with reduced clinical severity, inpatient mortality, and serum levels of C-reactive protein (CRP) among patients infected with COVID-19, according to a study published online Sept. 25 in PLOS ONE<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n 14 Novel Loci Identified for Abdominal Aortic Aneurysm<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — In a genome-wide association study (GWAS), published online Sept. 28 in Circulation<\/i>, researchers identified 14 novel loci for abdominal aortic aneurysm (AAA).<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <10 Percent of U.S. Population Has Antibodies to SARS-CoV-2<\/font><\/p>\n MONDAY, Sept. 28, 2020 (HealthDay News) — Fewer than 10 percent of the U.S. adult population formed antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first wave of the pandemic, according to a study published online Sept. 25 in The Lancet<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Physician’s Briefing Weekly Coronavirus Roundup<\/font><\/p>\n Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 21 to 25, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.<\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n U.S. Non-English Speakers Less Likely to Have SARS-CoV-2 Test<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — Non-English speakers are less likely to have completed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and have a higher proportion of positive tests compared with English speakers, according to a research letter published online Sept. 24 in JAMA Network Open<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n One-Fifth of Those With SARS-CoV-2 Infection Asymptomatic<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — About one-fifth of individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are asymptomatic and their viral load is comparable to that of patients with mild symptoms, according to a study published online Sept. 22 in Thorax<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Fertility Treatment Cancellations Due to COVID-19 Impact Mental Health<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — Fertility treatment suspensions due to the COVID-19 pandemic have had a considerable negative impact on women’s mental health and quality of life, according to a study published online Sept. 18 in PLOS ONE<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Performance of Commercial SARS-CoV-2 Ab Tests Varies<\/font><\/p>\n FRIDAY, Sept. 25, 2020 (HealthDay News) — There is considerable variation in the performance of commercial kits for detecting antibodies against SARS-CoV-2, according to a study published online Sept. 24 in PLOS Pathogens<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — A Chinese pharmaceutical company claims its COVID-19 vaccine should available by early next year for distribution in the United States and other countries.<\/p>\n AP News<\/i> Article<\/a><\/p>\n United First U.S. Airline to Offer COVID-19 Testing for Passengers<\/font><\/p>\n THURSDAY, Sept. 24, 2020 (HealthDay News) — The first COVID-19 testing program for airline passengers in the United States will be introduced Oct. 15 by United Airlines.<\/p>\n CBS News<\/i> Article<\/a><\/p>\n Genetically Predicted BMI Increases Rheumatoid Arthritis Risk<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Genetically predicted body mass index (BMI) significantly increases the risk for rheumatoid arthritis (RA), according to a study published online Sept. 22 in Arthritis & Rheumatology<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n U.S. COVID-19 Death Toll Hits 200,000 as Cases Climb in 22 States<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — The U.S. COVID-19 death toll reached the tragic milestone of 200,000 on Tuesday, with at least 22 states now reporting a rise in new cases. Just last Monday, only nine states were reporting increases in new COVID-19 cases, CNN<\/i> reported. For the most part, the case spikes are showing up in the country’s heartland and the Midwest.<\/p>\n CNN<\/i> Article<\/a><\/p>\n Stricter Vaccine Approval Rules Coming From FDA<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Stricter guidelines for emergency use authorization of a vaccine against the new coronavirus could soon be issued by the U.S. Food and Drug Administration.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n J&J COVID-19 Vaccine Begins Final Stage of Clinical Trials<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — The final stage of clinical trials for Johnson & Johnson’s COVID-19 vaccine have started, the company announced Tuesday.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n Most People With SARS-CoV-2 Do Not Remain Asymptomatic<\/font><\/p>\n WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Most people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not remain asymptomatic, and the secondary attack rate is lower among contacts of people with asymptomatic infection, according to a review published online Sept. 22 in PLOS Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n AKI Occurs in 7 Percent of Those Hospitalized With COVID-19<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Acute kidney injury (AKI) occurs in 7 percent of patients hospitalized with COVID-19 and is associated with increased in-hospital mortality, according to a study published online Sept. 22 in the Clinical Journal of the American Society of Nephrology<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Rates of COVID-19 Infection Higher in Blacks, Hispanics<\/font><\/p>\n TUESDAY, Sept. 22, 2020 (HealthDay News) — Black and Hispanic individuals are experiencing an excess burden of severe acute respiratory syndrome coronavirus 2 infection, according to a study published online Sept. 22 in PLOS Medicine<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n CDC Removes New COVID-19 Guidelines Just Days After Posting Them<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — New U.S. Centers for Disease Control and Prevention website guidelines suggesting that the new coronavirus can be transmitted by tiny droplets over a distance greater than six feet and that indoor ventilation is crucial to prevent its spread were removed from the agency’s website late Monday morning.<\/p>\n The Washington Post<\/i> Article<\/a><\/p>\n AstraZeneca Releases COVID-19 Vaccine Trial Plans<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — AstraZeneca is the latest drug company to release details about human tests of its COVID-19 vaccine in response to public demand for such information. Americans have increasing doubts about a COVID-19 vaccine, and experts are worried that an unproven or unsafe vaccine may be released prematurely due to pressure from President Donald Trump, The New York Times<\/i> reported.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n COVID-19 Death Toll Nears 200,000 in the United States<\/font><\/p>\n MONDAY, Sept. 21, 2020 (HealthDay News) — As the U.S. COVID-19 case count neared 200,000 on Monday, public health experts debated whether the spread of the virus will continue to slow or a new surge will come, as cold weather returns to much of the country.<\/p>\n The New York Times<\/i> Article<\/a><\/p>\n Physician’s Briefing Weekly Coronavirus Roundup<\/font><\/p>\n Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 14 to 18, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.<\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n Read Full Article<\/a><\/p>\n CDC: Adult Obesity Increasing, Tied to Worse COVID-19 Outcomes<\/font><\/p>\n FRIDAY, Sept. 18, 2020 (HealthDay News) — Adult obesity is increasing, with considerable racial and ethnic disparities, according to new data from the U.S. Centers for Disease Control and Prevention.<\/p>\n More Information<\/a><\/p>\n More Than Half of Pregnant Women With COVID-19 Asymptomatic<\/font><\/p>\n FRIDAY, Sept. 18, 2020 (HealthDay News) — More than half of hospitalized pregnant women with COVID-19 are asymptomatic at admission, while pregnant women hospitalized for COVID-19-related illness have a higher prevalence of prepregnancy obesity and gestational diabetes, according to two studies published in the Sept. 16 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report<\/i>.<\/p>\n Abstract\/Full Text – Delahoy<\/a><\/p>\n Abstract\/Full Text – Panagiotakopoulos<\/a><\/p>\n Lower Proportion of Inpatients With COVID-19 Wear Glasses<\/font><\/p>\n FRIDAY, Sept. 18, 2020 (HealthDay News) — The proportion of inpatients with COVID-19 who wear eyeglasses for extended daily periods is lower than in the general population, according to a study published online Sept. 16 in JAMA Ophthalmology<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Editorial<\/a><\/p>\n Substance Use Disorder Linked to Increased Risk for COVID-19<\/font><\/p>\n THURSDAY, Sept. 17, 2020 (HealthDay News) — Substance use disorder (SUD) is associated with a higher risk for COVID-19 than that seen in the general population, as well as worse outcomes, according to a study published online Sept. 14 in Molecular Psychiatry<\/i>.<\/p>\n Abstract\/Full Text<\/a><\/p>\n Poll: Most Americans Do Not Trust Trump’s COVID-19 Vaccine Comments<\/font><\/p>\n TUESDAY, Sept. 15, 2020 (HealthDay News) — In a sign that Americans are becoming more wary about the safety of a COVID-19 vaccine, a new poll shows a majority of adults do not trust what President Donald Trump has said on vaccine development.<\/p>\n NBC News<\/i> Article<\/a><\/p>\n Factor V Activity Significantly Increased in Severe COVID-19<\/font><\/p>\n TUESDAY, Sept. 15, 2020 (HealthDay News) — Factor V activity is significantly increased in patients with severe COVID-19, according to a study published online Aug. 24 in the American Journal of Hematology<\/i>.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n Canada Reports No New COVID-19 Deaths for First Time in Six Months<\/font><\/p>\n MONDAY, Sept. 14, 2020 (HealthDay News) — For the first time in six months, Canada on Friday reported no new COVID-19 deaths.<\/p>\n CBS News<\/i> Article<\/a><\/p>\n AstraZeneca COVID-19 Vaccine Trial Restarts<\/font><\/p>\n MONDAY, Sept. 14, 2020 (HealthDay News) — Oxford University has announced that final-stage testing of a COVID-19 vaccine it is developing with drug maker AstraZeneca will restart following a pause last week after a serious side effect showed up in a volunteer.<\/p>\n